Long-term outcomes of pneumococcal meningitis in childhood and adolescence.
A vaccine to prevent pneumococcal meningitis (PM) has recently been introduced. However, contemporary data to inform cost-effectiveness analysis and justify its routine use are sparse. We examined the cognitive, educational, psychological and social outcomes of PM in childhood. We completed a population-based case-control study in two regions of the UK. Children and young people currently between 3 and 20 years of age that had been diagnosed with PM ≤14 years of age were identified from active regional surveillance. Controls were siblings or neighbours of similar age. Standardised questionnaires and neuropsychological testing was administered to assess IQ, educational attainments, memory, psychological distress, quality of life and hearing impairment. Data were available on 97 patients and 93 controls. Eighty-four patients had a sibling/neighbour-matched control. Both matched and unmatched analyses were completed, and results of the 84 matched comparisons were highly similar to the unmatched. For the total sample, controls were similar in age, ethnicity and socioeconomic status. Median age at meningitis was 11 months. Median time between meningitis and assessment was 6.0 years. In the matched analysis, partial or profound hearing impairment was reported in 14% of patients and 1% of controls. Patients had significantly lower mean full-scale IQ (p = 0.05), verbal IQ (p = 0.0008), numeracy (p = 0.02), total quality of life (p = 0.04), school functioning (p = 0.005), psychosocial functioning (p = 0.001) and psychological difficulties (p = 0.01). Parents of patients reported greater functional disability (p = 0.008), impairment in all aspects of quality of life (p = 0.001) and psychological difficulties (p < 0.0006). Findings for IQ were not materially different when analyses were repeated only in those without hearing impairment. In multivariate regression analysis that included both case-control status and hearing status, both being a patient (p = 0.001) and having profound hearing impairment (p = 0.001) were independently associated with lower full-scale IQ. Conclusions Pneumococcal meningitis is associated with major sequelae. Our findings strongly support the introduction of pneumococcal conjugate vaccine as part of routine childhood vaccination programmes internationally.
General and Adolescent Paediatrics Unit, UCL Institute of Child Health, London, UK. Deborah.Christie@uclh.nhs.uk
Deborah
D
Christie
Russell M
RM
Viner
Kyle
K
Knox
Pietro G
PG
Coen
Han
H
Wang
Haitham
H
El Bashir
Rosa
R
Legood
Bharat C
BC
Patel
Robert
R
Booy
D000293:Adolescent; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D004522:Educational Status; D005260:Female; D034381:Hearing Loss / Q000209:etiology; D006801:Humans; D007223:Infant; D007360:Intelligence; D008297:Male; D008568:Memory; D008586:Meningitis, Pneumococcal / Q000150:complications* / Q000523:psychology*; D001523:Mental Disorders / Q000209:etiology; D015999:Multivariate Analysis; D009483:Neuropsychological Tests; D011159:Population Surveillance; D011788:Quality of Life; D012044:Regression Analysis; D011795:Surveys and Questionnaires; D006113:United Kingdom; D055815:Young Adult
Clin Pediatr (Phila). 1996 Feb;35(2):72-8
8775479
N Engl J Med. 1997 Oct 2;337(14):970-6
9395430
Pediatr Infect Dis J. 1993 May;12(5):389-94
8327300
Brain. 2006 Feb;129(Pt 2):333-45
16364957
World Health Stat Q. 1986;39(2):138-44
3751104
Pediatrics. 2006 May;117(5):1688-94
16651325
Scand J Infect Dis. 2006;38(2):104-9
16449000
J Infect. 2006 Jun;52(6):433-9
16216329
J Child Psychol Psychiatry. 2005 Aug;46(8):850-8
16033633
Pediatrics. 1995 May;95(5):646-56
7536915
Arch Dis Child. 2000 Sep;83(3):231-3
10952641
Br J Psychiatry. 2000 Dec;177:534-9
11102329
Eur J Pediatr. 2006 May;165(5):285-9
16333641
Vaccine. 2005 Feb 25;23(14):1739-45
15705480
Clin Infect Dis. 1995 Dec;21(6):1390-7
8749621
J Child Psychol Psychiatry. 1992 Oct;33(7):1241-7
1400705
Med Care. 1999 Feb;37(2):126-39
10024117
JAMA. 2000 Mar 15;283(11):1460-8
10732936
N Engl J Med. 2004 Oct 28;351(18):1849-59
15509818
Lancet. 2002 Feb 2;359(9304):431-4
11844534
N Engl J Med. 2005 Jan 6;352(1):39-47
15635111
Pediatr Infect Dis J. 2001 Dec;20(12):1105-7
11740313
Epidemiol Infect. 1996 Aug;117(1):95-102
8760955
J Pediatr Psychol. 1991 Feb;16(1):39-58
1826329
Value Health. 2004 Jan-Feb;7(1):36-51
14720129
J Infect Dis. 2001 Jan 15;183(2):239-246
11120930
Clin Ther. 2003 Oct;25(10):2614-30
14667962
Acta Paediatr. 2009 Mar;98(3):543-7
19046349